Download FREE Report Sample
Download Free sampleA type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient?s blood. Then the gene for a special receptor that binds to a certain protein on the patient?s cancer cells is added to the T cells in the laboratory. The special receptor is called a chimeric antigen receptor (CAR). Large numbers of the CAR T cells are grown in the laboratory and given to the patient by infusion. CAR T-cell therapy is used to treat certain blood cancers, and it is being studied in the treatment of other types of cancer. Also called chimeric antigen receptor T-cell therapy.
CAR-T Cellular Immunotherapy Market contains market size and forecasts of CAR-T Cellular Immunotherapy in Global, including the following market information:
Global CAR-T Cellular Immunotherapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global CAR-T Cellular Immunotherapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Allogeneic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of CAR-T Cellular Immunotherapy include Fosun Kite Biotechnology, Gilead Sciences, Novartis and Bristol-Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CAR-T Cellular Immunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CAR-T Cellular Immunotherapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global CAR-T Cellular Immunotherapy Market Segment Percentages, by Type, 2021 (%)
Allogeneic
Autologous
Global CAR-T Cellular Immunotherapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global CAR-T Cellular Immunotherapy Market Segment Percentages, by Application, 2021 (%)
Hospital
Pharmacy
Other
Global CAR-T Cellular Immunotherapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global CAR-T Cellular Immunotherapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CAR-T Cellular Immunotherapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies CAR-T Cellular Immunotherapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Fosun Kite Biotechnology
Gilead Sciences
Novartis
Bristol-Myers Squibb
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
